October 20, 2016 9:05 PM ET


Company Overview of Ra Pharmaceuticals, Inc.

Company Overview

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its peptide chemistry platform delivers enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. The company’s lead product candidate is RA101495, an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). It also develops Factor D inhibition for age-related macular degeneration and geographic atrophy...

87 Cambridge Park Drive


Cambridge, MA 02140

United States

Founded in 2008

40 Employees





Key Executives for Ra Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 58
Chief Financial Officer and Executive Vice President of Operations
Age: 52
Chief Medical Officer
Age: 39
Director of Molecular Biology
Executive Director of Operations
Compensation as of Fiscal Year 2016.

Ra Pharmaceuticals, Inc. Key Developments

Ra Pharmaceuticals Seeks Acquisitions

Ra Pharmaceuticals, Inc. expects to use of the net proceeds from the offering of $86.25 million for the acquisition of businesses or technologies.

Ra Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt

Ra Pharmaceuticals, Inc. filed its Annual on Sep 30, 2016 for the period ending Dec 31, 2015. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Ra Pharmaceuticals, Inc. Presents at Jefferies 2016 Complement Therapeutics Summit, May-03-2016 10:45 AM

Ra Pharmaceuticals, Inc. Presents at Jefferies 2016 Complement Therapeutics Summit, May-03-2016 10:45 AM. Venue: Jefferies Conference Center, New York, United States. Speakers: Douglas A. Treco, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ra Pharmaceuticals, Inc., please visit www.rapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.